These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21061472)

  • 21. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Fibrinolytic Protease Producing
    D D; S JN; S MK; C SD
    Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30871149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development and production of a triase fibrinolytic preparation].
    Gavrilov OK; Murashova NS; Kozlova MA; Sirotenko AV; Subbotina LA
    Gematol Transfuziol; 1985 Aug; 30(8):51-6. PubMed ID: 3902558
    [No Abstract]   [Full Text] [Related]  

  • 27. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative study on plant latex proteases and their involvement in hemostasis: a special emphasis on clot inducing and dissolving properties.
    Rajesh R; Shivaprasad HV; Gowda CD; Nataraju A; Dhananjaya BL; Vishwanath BS
    Planta Med; 2007 Aug; 73(10):1061-7. PubMed ID: 17691056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring Agaricomycetes from the Paranaense rainforest (Misiones, Argentina) as an unconventional source of fibrinolytic enzymes.
    Acosta GA; Fonseca MI; Fariña JI; Zapata PD
    Mycologia; 2022; 114(2):242-253. PubMed ID: 35394849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of fibrinolytic metalloproteinases (colombienases) isolated from Bothrops colombiensis venom.
    Girón ME; Guerrero B; Salazar AM; Sánchez EE; Alvarez M; Rodríguez-Acosta A
    Toxicon; 2013 Nov; 74():116-26. PubMed ID: 23958522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on fibrinogen, fibrin, and blood coagulation of proteolytic extracts from fruits of Pseudananas macrodontes, Bromelia balansae, and B. hieronymi (Bromeliaceae) in comparison with bromelain.
    Errasti ME; Prospitti A; Viana CA; Gonzalez MM; Ramos MV; Rotelli AE; Caffini NO
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):441-9. PubMed ID: 26886361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of a protease from Euphorbia resinifera latex in human anticoagulant and antithrombotic activities.
    Siritapetawee J; Khunkaewla P; Thumanu K
    Chem Biol Interact; 2020 Sep; 329():109223. PubMed ID: 32781033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period.
    Ries M
    Semin Thromb Hemost; 1997; 23(3):247-52. PubMed ID: 9255905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-acting fibrinolytic enzymes in shark cartilage extract: potential therapeutic role in vascular disorders.
    Ratel D; Glazier G; Provençal M; Boivin D; Beaulieu E; Gingras D; Béliveau R
    Thromb Res; 2005; 115(1-2):143-52. PubMed ID: 15567466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 36. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and characterization of a novel, highly potent fibrinolytic enzyme from Bacillus subtilis DC27 screened from Douchi, a traditional Chinese fermented soybean food.
    Hu Y; Yu D; Wang Z; Hou J; Tyagi R; Liang Y; Hu Y
    Sci Rep; 2019 Jun; 9(1):9235. PubMed ID: 31239529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products.
    Arnesen H; Godal HC
    Scand J Haematol; 1973; 10(3):232-40. PubMed ID: 4797626
    [No Abstract]   [Full Text] [Related]  

  • 39. Procoagulant Substance and Mechanism of Myristica fragrans.
    Zhang Y; Xie P; Guo X; Kang W
    J Med Food; 2016 Nov; 19(11):1065-1073. PubMed ID: 27845864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.